{"id":"https://openalex.org/W2000218345","doi":"https://doi.org/10.1185/03007990903290886","title":"Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia","display_name":"Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia","publication_year":2009,"publication_date":"2009-09-29","ids":{"openalex":"https://openalex.org/W2000218345","doi":"https://doi.org/10.1185/03007990903290886","mag":"2000218345","pmid":"https://pubmed.ncbi.nlm.nih.gov/19785568"},"language":"en","primary_location":{"id":"doi:10.1185/03007990903290886","doi":"https://doi.org/10.1185/03007990903290886","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990903290886","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009401009","display_name":"Leiv Ose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Leiv Ose","raw_affiliation_strings":["Rikshospitalet, Lipid Clinic, Medical Department University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rikshospitalet, Lipid Clinic, Medical Department University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080101019","display_name":"Dragos Budinski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123396","display_name":"Kowa (United Kingdom)","ror":"https://ror.org/02ykxax89","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088742","https://openalex.org/I4210123396"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dragos Budinski","raw_affiliation_strings":["Kowa Research Europe Ltd, Wokingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kowa Research Europe Ltd, Wokingham, UK","institution_ids":["https://openalex.org/I4210123396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032552822","display_name":"Neil J. Hounslow","orcid":"https://orcid.org/0000-0002-9821-4941","observed_orcids":["https://orcid.org/0000-0002-9821-4941"]},"institutions":[{"id":"https://openalex.org/I4210123396","display_name":"Kowa (United Kingdom)","ror":"https://ror.org/02ykxax89","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210088742","https://openalex.org/I4210123396"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Neil Hounslow","raw_affiliation_strings":["Kowa Research Europe Ltd, Wokingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kowa Research Europe Ltd, Wokingham, UK","institution_ids":["https://openalex.org/I4210123396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046853816","display_name":"Valerie Arneson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valerie Arneson","raw_affiliation_strings":["PharmaNet Ltd, High Wycombe, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaNet Ltd, High Wycombe, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5009401009"],"corresponding_institution_ids":["https://openalex.org/I1281400175"],"apc_list":null,"apc_paid":null,"fwci":7.4053,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.97726763,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"25","issue":"11","first_page":"2755","last_page":"2764"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pitavastatin","display_name":"pitavastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/primary-hypercholesterolemia","display_name":"primary hypercholesterolemia","score":0.902999997138977},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8640000224113464},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.8529999852180481},{"id":"https://openalex.org/keywords/statin-comparison","display_name":"statin comparison","score":0.5289999842643738},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.7910000085830688},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2776692505","wikidata":"https://www.wikidata.org/wiki/Q412677","display_name":"Pitavastatin","level":3,"score":0.988572895526886},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.9700862169265747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8946439027786255},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7738720178604126},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.570949375629425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5412707924842834},{"id":"https://openalex.org/C2778402494","wikidata":"https://www.wikidata.org/wiki/Q599756","display_name":"National Cholesterol Education Program","level":4,"score":0.5381622314453125},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4997837543487549},{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.49465128779411316},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.4807262718677521},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.4611300528049469},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4546036124229431},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4272347688674927},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.423037588596344},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34419864416122437},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3273116946220398},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.29222020506858826},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.10090595483779907},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007990903290886","doi":"https://doi.org/10.1185/03007990903290886","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990903290886","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:19785568","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19785568","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W12423254","https://openalex.org/W20697582","https://openalex.org/W110324665","https://openalex.org/W424467158","https://openalex.org/W1964754630","https://openalex.org/W1965023277","https://openalex.org/W1972966413","https://openalex.org/W1973523240","https://openalex.org/W1979040664","https://openalex.org/W1984360552","https://openalex.org/W2002405990","https://openalex.org/W2004753352","https://openalex.org/W2013014511","https://openalex.org/W2038140751","https://openalex.org/W2043180355","https://openalex.org/W2044564545","https://openalex.org/W2048859524","https://openalex.org/W2049308410","https://openalex.org/W2051707451","https://openalex.org/W2052855730","https://openalex.org/W2057674977","https://openalex.org/W2067322348","https://openalex.org/W2082220828","https://openalex.org/W2089356907","https://openalex.org/W2095421226","https://openalex.org/W2100270330","https://openalex.org/W2101697950","https://openalex.org/W2106343349","https://openalex.org/W2116404316","https://openalex.org/W2121933788","https://openalex.org/W2124172014","https://openalex.org/W2128818358","https://openalex.org/W2140072878","https://openalex.org/W2140332812","https://openalex.org/W2153979750","https://openalex.org/W2154704322","https://openalex.org/W2164542079","https://openalex.org/W2517252201","https://openalex.org/W3021659692","https://openalex.org/W4210993071","https://openalex.org/W4238251256","https://openalex.org/W4242564969","https://openalex.org/W4256285396","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2138383075","https://openalex.org/W2026241165","https://openalex.org/W2085410261","https://openalex.org/W2066077668","https://openalex.org/W2002981713","https://openalex.org/W2117872028","https://openalex.org/W1983512991","https://openalex.org/W2378573795","https://openalex.org/W2081320206","https://openalex.org/W2367003971"],"abstract_inverted_index":{"OBJECTIVES:":[0],"The":[1,93,132,238,247],"primary":[2,28,88,315],"objective":[3],"of":[4,11,19,37,54,60,64,102,106,116,138,147,169,205,250,269,272,290],"this":[5],"study":[6,134,140],"was":[7,81,95,136,213,262],"to":[8,97,114,142,195,234,265,282,285],"demonstrate":[9,98],"equivalence":[10,100],"pitavastatin":[12,107,119,122,209,251,306],"compared":[13,108,188,215,298],"with":[14,27,86,109,189,216,299,314],"simvastatin":[15,125,129,190,220,235,253,266,286],"in":[16,25,83,207,218,240,267,274,287,292,312],"the":[17,65,99,139,199,208,219,257,275,293],"reduction":[18,271,289],"low-density":[20],"lipoprotein":[21,175],"cholesterol":[22,176,183],"(LDL-C)":[23],"levels":[24],"patients":[26,85,197,313],"hypercholesterolaemia":[29,89,316],"or":[30,90,128,317],"combined":[31,91,318],"dyslipidaemia.":[32,92,319],"Secondary":[33],"objectives":[34],"included":[35],"achievement":[36],"National":[38],"Cholesterol":[39],"Education":[40],"Program":[41],"Adult":[42],"Treatment":[43],"Panel":[44],"(NECP)":[45],"and":[46,58,62,181,193,244,252,280],"European":[47],"Atherosclerosis":[48],"Society":[49],"(EAS)":[50],"LDL-C":[51,170,201,206,241,273,291],"goals,":[52],"comparison":[53,279],"other":[55],"lipid":[56,232],"parameters,":[57],"assessment":[59],"safety":[61,248],"tolerability":[63],"two":[66,258],"statins.":[67],"RESEARCH":[68],"DESIGN":[69],"AND":[70],"METHODS:":[71],"A":[72],"prospective,":[73],"randomised,":[74],"active-controlled":[75],"double-blind,":[76],"double-dummy,":[77],"12-week":[78],"therapy":[79],"trial":[80,94,153],"conducted":[82],"857":[84],"either":[87],"designed":[96],"(non-inferiority":[101],"presumed":[103],"equipotent":[104],"doses)":[105],"simvastatin.":[110,148],"Patients":[111],"were":[112,242,254],"randomised":[113],"one":[115],"four":[117],"groups:":[118],"2":[120,163,210],"mg/day,":[121,124],"4":[123,225],"20":[126,191,221],"mg/day":[127],"40":[130,236],"mg/day.":[131],"main":[133],"limitation":[135],"restriction":[137],"population":[141],"those":[143],"eligible":[144],"for":[145],"administration":[146],"TRIAL":[149],"REGISTRATION:":[150],"This":[151],"clinical":[152],"has":[154],"been":[155],"registered":[156],"at":[157,256],"www.clinicaltrials.gov":[158],"NCT#":[159],"NCT00309777.":[160],"RESULTS:":[161],"Pitavastatin":[162,224,261],"mg":[164,192,211,222,226],"showed":[165,227],"significantly":[166],"better":[167],"reductions":[168,239],"(p":[171,178,185],"=":[172,179,186],"0.014),":[173],"non-high-density":[174],"(non-HDL-C)":[177],"0.021)":[180],"total":[182],"(TC)":[184],"0.041)":[187],"led":[194],"more":[196],"achieving":[198],"EAS":[200],"treatment":[202,310],"target.":[203],"Reduction":[204],"group":[212,278],"39%":[214],"35%":[217],"group.":[223,295],"similar":[228,255],"effects":[229],"on":[230],"all":[231],"parameters":[233],"mg.":[237],"44%":[243],"43%,":[245],"respectively.":[246],"profiles":[249],"dose":[259,277],"levels.":[260],"considered":[263],"superior":[264],"terms":[268],"percent":[270,288],"lower":[276],"proved":[281],"be":[283],"equivalent":[284],"higher-dose":[294],"CONCLUSION:":[296],"As":[297],"simvastatin,":[300],"an":[301,308],"established":[302],"first-line":[303],"lipid-lowering":[304],"agent,":[305],"is":[307],"efficacious":[309],"choice":[311]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}